Manufacturing

The company has two dedicated state-of-the-art production facilities located in Athens Greece, designed in accordance with EU cGMP requirements:

Oncology Oral Solid Dosage Forms (inaugurated in 2007)

• Product Forms: tablets (uncoated or coated) & hard gelatin capsules
• Molecules handled: Anastrozole, Bicalutamide, Exemestane, Finasteride, Flutamide, Hydroxyurea, Letrozole, Tamoxifen, Thioguanine & Gefitinib
• Granulation Capacity: up to 150kg
• Primary Packaging: blisters
• Full Capacity: 140 million tablets, 10 million capsules
• Accreditations: EU GMP, Gulf Countries Council (GCC), Health Canada, Therapeutic Goods Administration (TGA-Australia)
• Anvisa accreditation
• Russian authorities accreditation

Conventional Solid Dosage Forms (renovated in 2005)

• Product Forms: tablets (uncoated, coated, orodispersible and chewable), hard gelatin capsules.
• Molecules handled: more than thirty-five (35).
• Primary Packaging: blisters.
• Full Capacity: 500 million tablets, 40 million capsules.
• Accreditations: EU GMP, Gulf Countries Council (GCC), Health Canada, Therapeutic Goods Administration (TGA-Australia)
• Anvisa accreditation
• Russian authorities accreditation